Literature DB >> 20051593

Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1.

Margitta Elvers1, David Stegner, Ina Hagedorn, Christoph Kleinschnitz, Attila Braun, Marijke E J Kuijpers, Michael Boesl, Qin Chen, Johan W M Heemskerk, Guido Stoll, Michael A Frohman, Bernhard Nieswandt.   

Abstract

Platelet aggregation is essential for hemostasis but can also cause myocardial infarction and stroke. A key but poorly understood step in platelet activation is the shift of the principal adhesive receptor, alpha(IIb)beta(3) integrin, from a low- to high-affinity state for its ligands, a process that enables adhesion and aggregation. In response to stimulation of heterotrimeric guanosine triphosphate-binding protein or immunoreceptor tyrosine-based activation motif-coupled receptors, phospholipases cleave membrane phospholipids to generate lipid and soluble second messengers. An essential role in platelet activation has been established for phospholipase C (PLC) but not for PLD and its product phosphatidic acid. Here, we report that platelets from Pld1(-/-) mice displayed impaired alpha(IIb)beta(3) integrin activation in response to major agonists and defective glycoprotein Ib-dependent aggregate formation under high shear conditions. These defects resulted in protection from thrombosis and ischemic brain infarction without affecting tail bleeding times. These results indicate that PLD1 may be a critical regulator of platelet activity in the setting of ischemic cardiovascular and cerebrovascular events.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20051593      PMCID: PMC3701458          DOI: 10.1126/scisignal.2000551

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  53 in total

1.  The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism.

Authors:  G Kauffenstein; W Bergmeier; A Eckly; P Ohlmann; C Léon; J P Cazenave; B Nieswandt; C Gachet
Journal:  FEBS Lett       Date:  2001-09-14       Impact factor: 4.124

2.  Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides.

Authors:  V Martel; C Racaud-Sultan; S Dupe; C Marie; F Paulhe; A Galmiche; M R Block; C Albiges-Rizo
Journal:  J Biol Chem       Date:  2001-03-28       Impact factor: 5.157

3.  Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets.

Authors:  Bernhard Nieswandt; Valerie Schulte; Alexandra Zywietz; Marie-Pierre Gratacap; Stefan Offermanns
Journal:  J Biol Chem       Date:  2002-08-14       Impact factor: 5.157

Review 4.  Scientific and therapeutic advances in antiplatelet therapy.

Authors:  Deepak L Bhatt; Eric J Topol
Journal:  Nat Rev Drug Discov       Date:  2003-01       Impact factor: 84.694

5.  Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3).

Authors:  Cindy L Yap; Karen E Anderson; Sascha C Hughan; Sacha M Dopheide; Hatem H Salem; Shaun P Jackson
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

6.  Distinct glycoprotein Ib/V/IX and integrin alpha IIbbeta 3-dependent calcium signals cooperatively regulate platelet adhesion under flow.

Authors:  Warwick S Nesbitt; Suhasini Kulkarni; Simon Giuliano; Isaac Goncalves; Sacha M Dopheide; Cindy L Yap; Ian S Harper; Hatem H Salem; Shaun P Jackson
Journal:  J Biol Chem       Date:  2001-11-16       Impact factor: 5.157

7.  Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation.

Authors:  A Honda; M Nogami; T Yokozeki; M Yamazaki; H Nakamura; H Watanabe; K Kawamoto; K Nakayama; A J Morris; M A Frohman; Y Kanaho
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

8.  Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen.

Authors:  B Nieswandt; C Brakebusch; W Bergmeier; V Schulte; D Bouvard; R Mokhtari-Nejad; T Lindhout; J W Heemskerk; H Zirngibl; R Fässler
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

9.  Kindlin-3 is essential for integrin activation and platelet aggregation.

Authors:  Markus Moser; Bernhard Nieswandt; Siegfried Ussar; Miroslava Pozgajova; Reinhard Fässler
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

10.  Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibalpha mechanoreceptor.

Authors:  Mario Mazzucato; Paola Pradella; Maria Rita Cozzi; Luigi De Marco; Zaverio M Ruggeri
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

View more
  75 in total

1.  Phospholipase D as a therapeutic target in brain disorders.

Authors:  Craig W Lindsley; H Alex Brown
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

Review 2.  Arterial thrombosis--insidious, unpredictable and deadly.

Authors:  Shaun P Jackson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

3.  Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor.

Authors:  Robert R Lavieri; Sarah A Scott; Paige E Selvy; Kwangho Kim; Satyawan Jadhav; Ryan D Morrison; J Scott Daniels; H Alex Brown; Craig W Lindsley
Journal:  J Med Chem       Date:  2010-09-23       Impact factor: 7.446

4.  Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl(3)-induced occlusive thrombus formation in the inferior vena cava of mice.

Authors:  M V Joglekar; Jerry Ware; Jin Xu; Malinda E C Fitzgerald; Theodore Kent Gartner
Journal:  Platelets       Date:  2012-06-21       Impact factor: 3.862

5.  Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids.

Authors:  Maria A Frias; Suman Mukhopadhyay; Elyssa Lehman; Aleksandra Walasek; Matthew Utter; Deepak Menon; David A Foster
Journal:  J Biol Chem       Date:  2019-11-24       Impact factor: 5.157

Review 6.  The phospholipase D superfamily as therapeutic targets.

Authors:  Michael A Frohman
Journal:  Trends Pharmacol Sci       Date:  2015-02-03       Impact factor: 14.819

7.  Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis.

Authors:  Christoph Klatt; Irena Krüger; Saskia Zey; Kim-Jürgen Krott; Martina Spelleken; Nina Sarah Gowert; Alexander Oberhuber; Lena Pfaff; Wiebke Lückstädt; Kerstin Jurk; Martin Schaller; Hadi Al-Hasani; Jürgen Schrader; Steffen Massberg; Konstantin Stark; Hubert Schelzig; Malte Kelm; Margitta Elvers
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

Review 8.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

9.  Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence.

Authors:  Ramya Ganesan; Karen M Henkels; Lucile E Wrenshall; Yasunori Kanaho; Gilbert Di Paolo; Michael A Frohman; Julian Gomez-Cambronero
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

10.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.